Panelists discuss the progress and partnerships made by pharmaceutical companies, government, academia, and investors in the fight to control and end the pandemic, and offer ideas on how…
Steven Quay, MD, PhD, physician-scientist and CEO of Atossa Therapeutics, discusses ongoing clinical trials of two treatments for patients infected with SARS-CoV-2 and how certain therapeutics will continue…